Cronyxin 50 mg/g Oral Paste for Horses

Quốc gia: Vương quốc Anh

Ngôn ngữ: Tiếng Anh

Nguồn: VMD (Veterinary Medicines Directorate)

Thành phần hoạt chất:

Flunixin

Sẵn có từ:

Bimeda Animal Health Limited

Mã ATC:

QM01AG90

INN (Tên quốc tế):

Flunixin

Dạng dược phẩm:

Oral paste

Loại thuốc theo toa:

POM-V - Prescription Only Medicine – Veterinarian

Nhóm trị liệu:

Horses

Khu trị liệu:

Anti Inflammatory NSAID

Tình trạng ủy quyền:

Authorized

Ngày ủy quyền:

2018-11-01

Đặc tính sản phẩm

Issued: November 2018
AN: 01382/2017
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cronyxin 50 mg/g Oral paste for horses
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
1 gram of paste contains:
flunixin
50,0 mg
(as flunixin meglumine)
83,0 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral paste
White to off-white paste
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of acute inflammatory musculoskeletal disorders in horses
4.3
CONTRAINDICATIONS
Do not exceed the stated dose or duration of treatment.
Do not administer other NSAIDs or glucocorticosteroids concurrently or
within
24 hours of each other.
Do not use in animals suffering from cardiac, hepatic or renal
disease.
Do not use in animals suspected of having gastrointestinal ulceration
or bleeding.
Do not use in case of hypersensitivity to the active substance or to
any of the
excipients.
Do not use in dehydrated or hypovolaemic animals, except in the case
of
endotoxaemia or septic shock, as there is a potential risk of
increased renal toxicity.
Do not use in animals suffering from chronic musculoskeletal
disorders.
See also section 4.7.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Issued: November 2018
AN: 01382/2017
Page 2 of 5
Use of the veterinary medicinal product may lead to temporary relief
due to its
ameliorating effects on inflammatory signs. This may appear as
effective treatment of
the underlying disease.
The cause of the underlying inflammatory condition should be
determined and
treated with appropriate concomitant therapy.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Animals should be rested and a sufficient supply of drinking water has
to be ensured
during the course of treatment with the veterinary medicinal product.
Use in any animal less than 6 weeks of age or in aged animals may
involve
additional risk.
Special precautions to be taken by the person administerin